The trajectory of Viagra, initially marketed by copyright, presents a fascinating case study for backers considering the drug sector. Although its groundbreaking success and generation of countless in sales, the patent lapse has opened the door for generic medications, significantly reducing earnings potential . This shift raises doubts about the l